ASVRX
Price
$10.31
Change
+$0.01 (+0.10%)
Updated
Jul 13 closing price
Net Assets
3.01B
ROFIX
Price
$20.97
Change
-$0.19 (-0.90%)
Updated
Jul 13 closing price
Net Assets
1.36B
Interact to see
Advertisement

ASVRX vs ROFIX

ASVRX vs ROFIX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. ROFIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Hold and ROFIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 3.01B vs. ROFIX (1.37B). ASVRX pays higher dividends than ROFIX: ASVRX (0.42) vs ROFIX (0.00). ASVRX was incepted earlier than ROFIX: ASVRX (16 years) vs ROFIX (25 years). ASVRX (1.58) is less costly to investors than ROFIX (1.14). ROFIX is a more actively managed with annual turnover of: 51.00 vs. ASVRX (42.00). ASVRX has a lower initial minimum investment than ROFIX: ASVRX (2500) vs ROFIX (1000000). ROFIX annual gain was more profitable for investors over the last year : 30.49 vs. ASVRX (4.86). ROFIX return over 5 years is better than : 2.49 vs. ASVRX (-2.41).
ASVRXROFIXASVRX / ROFIX
Total Expense Ratio1.581.14139%
Annual Report Gross Expense Ratio1.581.14139%
Fund Existence16 years25 years-
Gain YTD20.04728.49370%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.01B1.37B221%
Annual Yield % from dividends0.420.00-
Returns for 1 year4.8630.4916%
Returns for 3 years9.5935.3327%
Returns for 5 years-2.412.49-97%
Returns for 10 years32.7777.2842%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLISX722.66N/A
N/A
Vanguard Large Cap Index Institutional
TBWIX23.33N/A
N/A
Thornburg Better World International I
SEHAX18.06N/A
N/A
SEI US Equity Factor Allocation A (SIIT)
MAMEX22.99N/A
N/A
MoA Mid Cap Equity Index Fund
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C